Diclofenac for Submassive PE

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The primary objective is to demonstrate the clinical benefits of diclofenac (added to standard anticoagulant therapy) over placebo in normotensive patients with acute symptomatic pulmonary embolism and right ventricular dysfunction. The secondary objective is to assess the safety after administration of diclofenac in normotensive patients with acute symptomatic pulmonary embolism and right ventricular dysfunction.
Epistemonikos ID: 154d67e5901e98646f4b2908b7e45278e2d8e73e
First added on: May 10, 2024